UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Immunity Feedback and Clinical Outcome in Colon Cancer Patients Undergoing Chemoimmunotherapy with Gemcitabine + FOLFOX followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Aldesleukin (GOLFIG-1 Trial)

Clinical cancer research, 2008-07, Vol.14 (13), p.4192-4199

2008

Link zum Volltext

Verfügbarkeit prüfen

Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees

Vaccines (Basel), 2022-05, Vol.10 (5), p.808

2022

Link zum Volltext

Verfügbarkeit prüfen

EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma

Advances in Hematology, 2012, Vol.2012, p.149780-11

2012

Link zum Volltext

Verfügbarkeit prüfen

Anatomy of an extensively drug-resistant Klebsiella pneumoniae outbreak in Tuscany, Italy

Proceedings of the National Academy of Sciences - PNAS, 2021-11, Vol.118 (48)

2021

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum: Haemagglutinin-neuraminidase from HPIV3 mediates human NK regulation of T cell proliferation via NKp44 and NKp46

Journal of general virology, 2018-09, Vol.99 (9), p.1344-1344

2018

Link zum Volltext

Verfügbarkeit prüfen

Brevibacterium casei bacteraemia in a port-a-cath carrier patient: a case report

Le infezioni in medicina, 2018-09, Vol.26 (3), p.263-265

2018

Link zum Volltext

Verfügbarkeit prüfen

Letter to the Editor: Why is influenza virus more risky for pregnant women?

Influenza and other respiratory viruses, 2010-09, Vol.4 (5), p.247-248

Cusi, Maria Grazia

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2232: Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase Ib program

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2232-2232

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2232: Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPPVAC phase Ib program

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2232-2232

2016

Link zum Volltext

Verfügbarkeit prüfen

Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects

Immunity & ageing, 2010-10, Vol.7 (1), p.14-14, Article 14

2010

Link zum Volltext

Verfügbarkeit prüfen

P2.03a-053 Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S921

2017

Link zum Volltext

Verfügbarkeit prüfen

P2.03a-053 Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab: Topic: Clinical Trials

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S921-S921

2017

Link zum Volltext

Verfügbarkeit prüfen

Seroprevalence of hepatitis E virus (HEV) infection in blood donors and renal transplant recipients: a retrospective study from central Italy

Le infezioni in medicina, 2015-09, Vol.23 (3), p.253-256

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-229: Treatment of advanced cancer patients with a newest poly-epitope peptide vaccine to the thymidylate synthase(TSPP): a phase Ib (TSPP/VAC1) trial

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.LB-229-LB-229

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib study of TSPP (thymidilate synthase poly-epitope peptide) vaccine in combination with GOLFIG chemoimmuno-burst in advanced colon cancer patients: Results from the TSPP/VAC-1/c trial

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e13098-e13098

2012

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory status affects the antitumor activity of poly-epitope-peptide vaccination against the thymidylate synthase in metastatic colo-rectal cancer patients enrolled in TSPP/VAC-1 Phase Ib trial

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P443-P443

2015

Link zum Volltext

Verfügbarkeit prüfen

A Mediterranean Arbovirus: The Toscana Virus

Journal of neurovirology, 2003, Vol.9 (6), p.577-583

2003

Link zum Volltext

Verfügbarkeit prüfen

Chlamydia pneumoniae viability in atherosclerotic tissue: True or false? / Reply

The Journal of infectious diseases, 2000-11, Vol.182 (5), p.1577

2000

Link zum Volltext

Verfügbarkeit prüfen

Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID

Viruses, 2023, Vol.15 (3)

2023

Link zum Volltext

Verfügbarkeit prüfen

Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female

Journal of Asthma, 2021, Vol.58 (8), p.1128-1131

2021

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 in pleural fluid in a kidney transplant patient

Postgraduate Medicine, 2021, Vol.133 (5), p.540-543

2021

Link zum Volltext

Verfügbarkeit prüfen

Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection

Joint bone spine, 2018, Vol.85 (1), p.129-130

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)

Publikationsform

Artikel
(24)
Berichte
(4)

Sprache

Englisch
(28)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunity Feedback and Clinical Outcome in Colon Cancer Patients Undergoing Chemoimmunotherapy with Gemcitabine + FOLFOX followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Aldesleukin (GOLFIG-1 Trial)

Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees

Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine

EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma

Anatomy of an extensively drug-resistant Klebsiella pneumoniae outbreak in Tuscany, Italy

Corrigendum: Haemagglutinin-neuraminidase from HPIV3 mediates human NK regulation of T cell proliferation via NKp44 and NKp46

Brevibacterium casei bacteraemia in a port-a-cath carrier patient: a case report

Letter to the Editor: Why is influenza virus more risky for pregnant women?

Abstract 2232: Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase Ib program

Abstract 2232: Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPPVAC phase Ib program

Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects

P2.03a-053 Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab

P2.03a-053 Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab: Topic: Clinical Trials

Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev)

Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients

Seroprevalence of hepatitis E virus (HEV) infection in blood donors and renal transplant recipients: a retrospective study from central Italy

Abstract LB-229: Treatment of advanced cancer patients with a newest poly-epitope peptide vaccine to the thymidylate synthase(TSPP): a phase Ib (TSPP/VAC1) trial

Phase Ib study of TSPP (thymidilate synthase poly-epitope peptide) vaccine in combination with GOLFIG chemoimmuno-burst in advanced colon cancer patients: Results from the TSPP/VAC-1/c trial

Inflammatory status affects the antitumor activity of poly-epitope-peptide vaccination against the thymidylate synthase in metastatic colo-rectal cancer patients enrolled in TSPP/VAC-1 Phase Ib trial

A Mediterranean Arbovirus: The Toscana Virus

Chlamydia pneumoniae viability in atherosclerotic tissue: True or false? / Reply

Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID

Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female

SARS-CoV-2 in pleural fluid in a kidney transplant patient

Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection

Aktive Filter

Suchergebnisse filtern